Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR

被引：0

作者：

Welte, T. ^{[1
]}

Menzies-Gow, A. ^{[2
]}

Israel, E. ^{[3
]}

Corren, J. ^{[4
]}

Hunter, G. ^{[5
]}

Cook, W. ^{[6
]}

Colice, G. ^{[5
]}

Lanos-Ackert, P. J. ^{[7
]}

机构：

[1] Hannover Med Sch, Klin Pneumol, D-30625 Hannover, Germany

[2] Royal Brompton Hosp London, Resp Med, London, England

[3] Arvard Med Sch Boston, Boston, MA USA

[4] Univ Calif, David Geffen Sch Med, Davis, CA USA

[5] Astrazeneca, Cambridge, England

[6] Astrazeneca, Biopharmaceut Med, Resp & Immunol, Cambridge, England

[7] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA

来源：

PNEUMOLOGIE | 2022年 / 76卷

关键词：

D O I：

10.1055/s-0042-1747712

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Po 88

引用

页码：S12 / S12

页数：1

共 50 条

[31] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY PRIOR OMALIZUMAB USE: A POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
Menzies-Gow, A.
Colice, G.
Ambrose, C. S.
Martin, N.
Llanos, J. P.
Hellqvist, A.
Cook, B.
Caminati, M.
THORAX, 2023, 78 (SUPPL_4) : A273 - A274
[32] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES
Corren, Jonathan
Wechsler, Michael E.
Chupp, Geoffrey L.
Ambrose, Christopher
Roseti, Stephanie L.
Hellqvist, Asa
Ackert, Jean-Pierre Llanos
Martin, Neil
Colice, Gene L.
CHEST, 2022, 162 (04) : 21A - 22A
[33] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Prior Omalizumab Use: A Post Hoc Analysis of the Phase 3 Navigator Study
Menzies-Gow, A.
Colice, G.
Ambrose, C. S.
Llanos, J.
Hellqvist, A.
Cook, B.
Caminati, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[34] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
Kraft, Monica
Colice, Gene L.
Ambrose, Christopher
Cook, William
Hunter, Gillian
Molfino, Eleonora A.
Martin, Neil
Roseti, Stephanie L.
CHEST, 2022, 162 (04) : 11A - 12A
[35] Effect of tezepelumab on exacerbation-related intravenous corticosteroid use in patients with severe, uncontrolled asthma in NAVIGATOR
Bourdin, A.
Martin, N.
Ambrose, C.
Ponnarambil, S.
Hunter, G.
Molfino, N.
Cook, B.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[36] Clinical Responses to Treatment with Tezepelumab Among Patients with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
Lugogo, N. L.
Ambrose, C. S.
Colice, G.
Kmita, K.
Cook, B.
Ponnarambil, S.
Ackert, J. Llanos
Menzies-Gow, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[37] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
Menzies-Gow, Andrew
Corren, Jonathan
Bourdin, Arnaud
Chupp, Geoffrey
Israel, Elliot
Griffiths, Janet
Hellqvist, Asa
Bowen, Karin
Kaur, Primal
Almqvist, Gun
Ponnarambil, Sandhia
Colice, Gene
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
[38] Tezepelumab in the Treatment of Uncontrolled Severe Asthma
Feist, Jacqueline
Lipari, Melissa
Kale-Pradhan, Pramodini
ANNALS OF PHARMACOTHERAPY, 2023, 57 (01) : 62 - 70
[39] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR
Wechsler, Michael E.
Chupp, Geoffrey L.
Israel, Elliot
Castro, Mario
Bober, Magdalena
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher S.
CHEST, 2024, 166 (04) : 4664A - 4680A
[40] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND HIGH BASELINE BLOOD EOSINOPHIL COUNTS
Jain, N.
Llanos-Ackert, J.
Ambrose, C.
Cook, B.
Ponnarambil, S.
Martin, N.
Webb, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S36 - S37

← 1 2 3 4 5 →